August 21, 2012 at 10:45 AM EDT
NPS Pharma (NPSP): FDA Schedules Meeting For Experimental Bowel Drug Gattex
NPS Pharmaceuticals Inc. (NASDAQ:NPSP) said it has received a notice from the U.S. regulatory authorities that its new experimental bowel drug Gattex will be discussed at advisory committee meeting. [More...]
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here